Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AM-3102 is an OEA analog that stimulates PPARα transcriptional activity and prolongs feeding latency. It is resistant to enzymatic hydrolysis and is as potent as OEA in enhancing transcriptional activity of PPARα and reducing food intake in free-feeding rats. AM3102 demonstrates weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 110.00 | |
10 mg | 35 days | $ 210.00 | |
50 mg | 35 days | $ 853.00 |
Description | AM-3102 is an OEA analog that stimulates PPARα transcriptional activity and prolongs feeding latency. It is resistant to enzymatic hydrolysis and is as potent as OEA in enhancing transcriptional activity of PPARα and reducing food intake in free-feeding rats. AM3102 demonstrates weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. |
Synonyms | KDS-5104, AM 3102, Methyl oleoylethanolamide |
Molecular Weight | 339.56 |
Formula | C21H41NO2 |
CAS No. | 213182-22-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AM-3102 213182-22-0 KDS-5104 AM3102 KDS 5104 KDS5104 AM 3102 Methyl oleoylethanolamide inhibitor inhibit